Position in AQST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,040,000
+$2,500 QoQ
Shares Held
250,000
0.0% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#45
of 185 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rosalind Advisors, Inc. holds $37,825,481 across 5 Drug Manufacturers - Specialty & Generic names. AQST ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,908,981 | $23,039,129 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
721,504 | $7,215,040 | |
| 3 | TLPH |
Talphera, Inc.
|
5,169,501 | $5,324,586 | |
| 4 | BFRI |
Biofrontera Inc.
|
1,275,609 | $1,206,726 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
This page
|
250,000 | $1,040,000 |
All Filings in AQST
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,040,000 | 250,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,037,500 | 250,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||